Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools

Sponsor
Singapore Chung Hwa Medical Institution (Other)
Overall Status
Recruiting
CT.gov ID
NCT05563090
Collaborator
Ministry of Health, Singapore (Other)
250
1
27.5
9.1

Study Details

Study Description

Brief Summary

The investigators aim to objectively identify the Traditional Chinese Medicine (TCM) syndrome differentiation of type II diabetic and prediabetic patients in Singapore through modern technologies thereby potentially increasing the accuracy of identification, diagnosis, and prevention of diabetes and prediabetes through a system of targeted treatment. This observational study integrates the concept of TCM diagnostic methods with modern tools aim to provide an objective view on the syndrome differentiation of diabetic and prediabetic patients in Singapore and hence provide a guideline in the treatment options targeted specifically at Singaporeans demographic.

A total of 250 subjects with 50 allocated in each group will be recruited to ensure a sufficient sample size for statistical analysis of the diabetic and prediabetic syndrome differentiation. Subjects aged 21-65 years old, of either gender, with no limitations on race, and is diagnosed with either diabetes (FPG ≥ 7.0 mmol/L, or 2hPG ≥ 11.1mmol) or prediabetes (IFG of FPG 6.1-6.9 mmol/L, and/or IGT with 2hPG of 7.8-11.0 mmol/L) will be included.

Subjective and objective assessments through health evaluation, Physical Activity Questionnaire and Sugar Intake, Constitution in Chinese Medicine Questionnaire, radial pulse diagnosis and tongue diagnosis will be performed for each subject in a single visit. Statistical analysis of assessments will be conducted using unpaired t-test with significance level of p<0.05. Statistical software SPSS 15.0 (SPSS Inc.) will be used for the analysis.

Condition or Disease Intervention/Treatment Phase
  • Other: Questionnaires+Tongue diagnosis+Pulse diagnosis

Detailed Description

Singapore's age-adjusted comparative prevalence of diabetes is at 5.5% in 2019 down from 10.2% in 2010, whereas the global average is at 8.3%. However, approximately 640,000 Singapore citizens 18 years and above are diagnosed with diabetes, and around 650,000 citizens are prediabetic.

The investigators aim to objectively identify the Traditional Chinese Medicine (TCM) syndrome differentiation of type II diabetic and prediabetic patients in Singapore through modern technologies thereby potentially increasing the accuracy of identification, diagnosis, and prevention of diabetes and prediabetes through a system of targeted treatment.

The investigators hypothesize that the TCM syndrome differentiation of 'xiao-ke' in Singapore is different from that of the ones defined in TCM Internal Medicine, which is based on China demographics.

This observational study integrates the concept of TCM diagnostic methods with modern tools aim to provide an objective view on the syndrome differentiation of diabetic and prediabetic patients in Singapore and hence provide a guideline in the treatment options targeted specifically at Singaporeans demographic.

The investigators will attempt to recruit a total of 250 subjects with 50 allocated in each group to ensure a sufficient sample size for statistical analysis of the diabetic and prediabetic syndrome differentiation. Subjects aged 21-65 years old, of either gender, with no limitations on race, and is diagnosed with either diabetes (FPG ≥ 7.0 mmol/L, or 2hPG ≥ 11.1mmol) or prediabetes (IFG of FPG 6.1-6.9 mmol/L, and/or IGT with 2hPG of 7.8-11.0 mmol/L) will be included.

Subjective and objective assessments through health evaluation, Physical Activity Questionnaire and Sugar Intake, Constitution in Chinese Medicine Questionnaire, radial pulse diagnosis and tongue diagnosis will be performed for each subject in a single visit. Statistical analysis of assessments will be conducted using unpaired t-test with significance level of p<0.05. Statistical software SPSS 15.0 (SPSS Inc.) will be used for the analysis.

Study Design

Study Type:
Observational
Anticipated Enrollment :
250 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Patients in Singapore Using Digitalized TCM Diagnostic Tools: an Observational Study
Actual Study Start Date :
Sep 17, 2022
Anticipated Primary Completion Date :
Sep 30, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
0HEA

Healthy or sub-healthy subject without clinically diagnosed chronic conditions such as diabetes, hypertension or dyslipidemia

Other: Questionnaires+Tongue diagnosis+Pulse diagnosis
Each subject will undergo questionnaires, tongue and pulse diagnosis using modern diagnostic tools

1PRE

Prediabetes with IFG of FPG 6.1-6.9 mmol/L, and/or IGT with 2hPG of 7.8-11.0 mmol/L

Other: Questionnaires+Tongue diagnosis+Pulse diagnosis
Each subject will undergo questionnaires, tongue and pulse diagnosis using modern diagnostic tools

2DIA

Diabetes with FPG of ≥ 7.0 mmol/L, 2hPG of ≥ 11.1mmol, or HbA1c of > 6.5%

Other: Questionnaires+Tongue diagnosis+Pulse diagnosis
Each subject will undergo questionnaires, tongue and pulse diagnosis using modern diagnostic tools

3PREHD

Prediabetes with hypertension and dyslipidemia

Other: Questionnaires+Tongue diagnosis+Pulse diagnosis
Each subject will undergo questionnaires, tongue and pulse diagnosis using modern diagnostic tools

4DIAHD

Diabetes with hypertension and dyslipidemia

Other: Questionnaires+Tongue diagnosis+Pulse diagnosis
Each subject will undergo questionnaires, tongue and pulse diagnosis using modern diagnostic tools

Outcome Measures

Primary Outcome Measures

  1. The Constitution in Chinese Medicine Questionnaire (CCMQ) [One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.]

    The CCMQ, published by the China Association of Chinese Medicine in 2009, will be adopted to assess the body constitution of each subjects based on TCM principles [26]. Refer to Annex 3. There are nine different types of body constitution, including (a) Normality; (b) Qi deficiency; (c) Yin deficiency; (d) Yang deficiency; (e) Phlegm-dampness; (f) Damp-heat; (g) Blood stasis; (h) Qi depressed; (i) Inherited special constitution. Each subject will answer seven to eight questions in each category. The scoring algorithm indicates the likelihood of a specific type of body constitution with a higher score.

  2. Physical Activity Questionnaire and sugar intake [One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.]

    Level of physical activity related to the last three months will be recorded through the Physical Activity Questionnaire. Sugar intake includes sweet or carbonated drinks, desserts like chocolates and cakes, 0 - 2, 3 - 6, or more than 7 times a week will also be recorded. Refer to Annex 2. This will help to identify the risk factors involved and identify the correlation between the body constitutions and various types of 'xiao-ke' based on TCM syndrome differentiation.

  3. Pulse sphygmograph [One-time assessment within 30mins after undergoing the questionnaires]

    The Asia Plus Pen Pulse Analysis System Model PPAS-93 (Asia Plus Bio Tech Co., Ltd, Taiwan) would be used in the identification of RPPW of the subjects in this study. The Asia Plus Pen Pulse Analysis System Model PPAS-93 (Figure 11) is a noninvasive device that consist of a high precision pressure sensor pen and a pulse analyzer. The 3D pulse detector is a handheld pen that digitalizes the biological signal of RPPW and provides a graphical analysis. The electronic device contains a high precision pressure sensor, a filter, an amplifier, and a signal recording card connected to signal analysis software. The frequency response is 0.1-50 Hz, and the sampling rate is 3000 Hz.

  4. Tongue imaging device [One-time assessment within 30mins after undergoing the questionnaires]

    China Artificial Intelligence Health Status Identification System Model Number YZKJ-SMZY-1AI (Figure 12) will be used in the imaging and analysis of the subject's tongue. The noninvasive device captures the image of the tongue through an inbuilt camera supported by LED lights within the device. A monitor that is connected to the imaging device would provide a live video feedback on the positioning of the tongue. The images of the subjects' face, tongue, and sublingual collaterals will then be compared and analyzed for the similarities against standard images of tongue analysis using an artificial intelligence system.

Secondary Outcome Measures

  1. Health Evaluation - Age [One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.]

    Demographic information eg age in years will be collected.

  2. Health Evaluation - Gender [One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.]

    Demographic information eg gender will be collected.

  3. Health Evaluation - Weight [One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.]

    Weight in kilogram will be recorded

  4. Health Evaluation - Height [One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.]

    Height in meters will be recorded

  5. Health Evaluation - BMI [One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.]

    Weight in kilogram and height in meters will be aggregated to derive the BMI in kg/m^2.

  6. Health Evaluation - blood sugar level [One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.]

    Blood glucose in fasting, 2hPG or HbA1c (in mmol/L) results if available in patient's regular blood test report

  7. Health Evaluation - Vital signs [One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.]

    Vital signs including systolic blood pressure, diastolic blood pressure in mmHg

  8. Health Evaluation - Radial pulse rate [One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.]

    Vital signs including radial pulse rate (bpm)

  9. Health Evaluation - Medications [One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.]

    Western and Chinese medications and nutritional supplements consumed by the subjects will be recorded to identify possible intervention and correlation towards TCM syndrome differentiation.

  10. Health Evaluation - Existing symptoms [One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.]

    The existing symptoms of subjects will be recorded to identify the possible correlation towards TCM syndrome differentiation.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Aged 21-65 years old, inclusive;

  • Clinically diagnosed with one of the following:

  1. Type II Diabetes Mellitus with or without hypertension and dyslipidemia

  2. Prediabetes with or without hypertension and dyslipidemia

  3. Healthy or sub-healthy subject without clinically diagnosed chronic conditions such as diabetes, hypertension or dyslipidemia

Exclusion Criteria:
  • Subjects diagnosed with Gestational Diabetes

  • Subjects who are pregnant or lactating

  • Subjects with chronic heart failure, history of carcinomas with treatment of chemotherapy/radiotherapy, psychological, or psychiatric disorders

  • Subjects with heart diseases and transplanted devices such as pacemakers;

  • Subjects with acute infections such as upper respiratory infections, acute gastroenteritis, or urinary tract infections;

  • Subjects unable to undergo evaluation with the pulse sphygmograph, tongue detection or complete the questionnaire;

  • Subjects with communication disorders

  • Subjects with gastroenterology diseases or are diagnosed with 'spleen and stomach deficiency' (脾胃虚弱)

  • Subjects undergoing TCM treatment for diabetes or pre-diabetes within 1 week

Contacts and Locations

Locations

Site City State Country Postal Code
1 Singapore Chung Hwa Medical Institution Singapore Singapore 319522

Sponsors and Collaborators

  • Singapore Chung Hwa Medical Institution
  • Ministry of Health, Singapore

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Singapore Chung Hwa Medical Institution
ClinicalTrials.gov Identifier:
NCT05563090
Other Study ID Numbers:
  • SCHMI-2022-001
First Posted:
Oct 3, 2022
Last Update Posted:
Oct 3, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Singapore Chung Hwa Medical Institution
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 3, 2022